FDA Approves AlloMap To Help With Heart Transplants

August 28, 2008

The U.S. Food and Drug Administration (FDA) has approved a new tool to help with heart transplants.  The new tool is in the form of a blood test known as AlloMap....Boston (ChattahBox) – The U.S. Food and Drug Administration (FDA) has approved a new tool to help with heart transplants. The new tool is in the form of a blood test known as AlloMap.

The FDA approved the new blood test this week and should help both doctors and patients with heart transplants.

Currently, patients need to go through biopsies to see if their body is rejecting their new organ.

This new blood test though, AlloMap, does away with that.

This new non-invasive test works to look over genetic information which is found in white blood cells.

With this information, they can then check on the organ without a biopsy.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.